Abstract
Adeno-associated virus (AAV) can only replicate when additional functions are supplied via a co-infection with a helper virus (typically an adenovirus or herpesvirus) or co-transfection with helper virus genes. Use of the baculovirus expression system for recombinant (r)AAV gene therapy vector production in insect cells is becoming more common, although the helper functions provided by the baculovirus have not been identified. We first review the basics of AAV biology and the production of rAAVs in insect cells. We describe adenovirus and herpes simplex 1 virus helper genes to identify functional homologs in the baculovirus genome. Next, we provide a shortlist of candidate baculovirus genes that are likely involved in cell cycle coordination, DNA synthesis, promoter transactivation, and stress response modulation to support AAV replication. We provide experimental approaches to identify direct and/or indirect interactions between baculovirus gene products and AAV during replication, capsid synthesis and genome packaging. This work contributes to our fundamental understanding of baculovirus-AAV interactions, supporting the rational engineering of improved rAAV production in insect cells.
Keywords: adeno-associated virus, gene therapy, baculovirus, baculovirus expression vector system, helper virus, viral vectors
Graphical abstract

De Jong and colleagues review how baculovirus enables adeno-associated virus replication in insect-cell systems. By identifying candidate helper genes and outlining strategies to dissect their roles, the work advances mechanistic understanding and supports the development of more efficient, scalable gene therapy vector production platforms.
Introduction
Since adeno-associated virus (AAV) derived vectors have proven to be highly suitable for applications in gene therapy, their efficient production at a large scale has become important. What specifically makes the production of recombinant (r)AAVs challenging is that AAV (family Parvoviridae; subfamily Parvovirinae, genus Dependoparvovirus) cannot complete its replication cycle without specific helper functions being supplied.1,2 Initially, these helper functions were delivered to mammalian cells via co-infection with a known helper virus, most commonly an adenovirus (AdV) or herpes simplex virus (HSV).1,3,4 To ensure safety of the therapeutic end product, the separation of the co-infecting pathogenic AdV or HSV from the rAAV vectors is necessary, which makes for a complex and expensive downstream processing process. Since then, the rAAV production process has undergone substantial development and the production of rAAV in mammalian cells is mediated by co-transfection with plasmids providing the viral helper elements (AdV5 VA RNA, E2a, and E4orf6) together with the components to assemble the rAAV vector (Rep, Cap, and a gene of interest [GOI]).5,6,7 More recently, mammalian producer cell lines have been developed, that stably or inducibly express required AAV genes, thereby simplifying and optimizing the system considerably.8,9 Although the omission of infectious helper viruses from the production process increases the safety, the scalability remains challenging due to the limitations of plasmid DNA transfections compared to helper virus infections.
In the early 2000s, another method for the generation of rAAVs was described based on the baculovirus expression vector system (BEVS) in insect cells.10 Enabled by the strong promoters offered by the BEVS, rAAV was produced in Spodoptera frugiperda 9 (Sf9) cells grown in suspension that were infected with three recombinant baculoviruses, each harboring one of the rAAV components (AAV Rep, Cap or GOI). In the years that followed, improvements to the BEVS-rAAV system were reported, mainly through increasing the stability of the transgene cassettes and by reducing the number of baculoviruses required for production.11,12 These studies demonstrated that high yield rAAV production with the BEVS in insect cells is possible without AdV or HSV helper functions, and led to the first rAAV product ever that received market authorization by the European Medicines Agency (EMA); Alipogene tiparvovec (Glybera, Uniqure), a gene therapy treatment designed to overcome lipoprotein lipase deficiency.13 Since then, the EMA and US Food and Drug Administration (FDA) have approved more rAAV therapeutics that were produced with the BEVS; Valoctocogene roxaparvovec (Roctavian; Biomarin) and Etranacogene dezaparvovec (Hemgenix, UniQure & CSL Behring LLC) for the treatment of hemophilia A and B, respectively.14,15
Little is known about which baculovirus genes, proteins and/or processes play a role in directly supporting AAV replication in insect cells, and/or indirectly providing support by creating a permissive intracellular environment, despite the fact that helper functions have been extensively studied for mammalian helper viruses. Since its first description for rAAV in 2002, multiple experimental and review papers have covered the BEVS as a production platform for rAAVs. Subsequently, this has contributed to progress in process optimization, a better understanding of baculovirus co-infection kinetics, optimization of the Cap sequence to achieve the desired capsid protein stoichiometry, as well as the generation of rAAV packaging insect cell lines.16,17,18 However, despite all these developments important fundamental questions are left unanswered regarding the molecular interactions between baculovirus and AAV replication. There are plausible indirect mechanisms by which baculovirus proteins and the baculovirus-infected cell state provide the helper environment for AAV replication, but the protein interactions have not been well characterized in the literature. A deeper understanding of these interactions might lead to additional process improvements, which in turn might lead to reduction in process costs, all aiding toward making rAAV gene therapies more affordable. In this review, we discuss AAV biology and BEVS-mediated rAAV production, highlight the importance of host cell environment, and nominate baculoviral gene candidates for further study. Lastly, we describe a future experimental workflow to better define these interactions.
Adeno-associated virus
Taxonomy
Members of the family Parvoviridae are characterized by a small, non-enveloped capsid containing a linear, single-stranded DNA (ssDNA) genome of approximately 4–6 kb.19 A defining hallmark of this family is their conserved mechanism of genome replication, known as rolling hairpin replication (RHR).20 This replication strategy relies on terminal hairpin structures flanking the coding part of the genome, which serve as self-priming origins of DNA synthesis. While mechanistically related to rolling-circle replication (RCR), used by, for instance, bacteriophages21 and geminiviruses,22 RHR is distinct in its reliance on linear DNA templates flanked by hairpin termini.23 All members of the Parvoviridae encode replication initiator proteins that are functionally conserved and responsible for origin recognition, site-specific nicking, and helicase activity.19 This conservation spans vertebrate-infecting viruses, including AAV, as well as viruses that infect invertebrate hosts, such as those in the Densovirinae sub-family. The members of the Densovirinae are able to autonomously replicate in invertebrates, without the need for helper virus functions.24 The shared replication logistics across parvoviruses implies that AAV replication might be supported in insect cells, which was eventually validated experimentally.10
Taxonomically, AAV belongs to the genus Dependoparvovirus in the Parvovirinae sub-family, within the Parvoviridae family (Figure 1A).19 Despite the genus name implying obligate dependence on helper viruses, this requirement is not universal. Autonomously replicating viruses such as goose parvovirus (GPV) and Muscovy duck parvovirus (MDPV) are classified within the same genus yet replicate independently of helper viruses (Figure 1B).30,31,32 Comparative sequence analyses reveal a substantial similarity of approximately 61% between AAV and GPV genomes, and evolutionary studies suggest that these autonomous and non-autonomous dependoparvoviruses share a common ancestor.31,33 Studies of the AAV life cycle indicate that the block to autonomous replication occurs at multiple discrete stages. In the absence of helper virus functions, AAV is impaired in efficient second-strand DNA synthesis. This also affects the transcription of the viral genome by host RNA polymerase II, preventing expression of genes for replication and subsequent genome replication.30,31,34 These deficiencies contrast with the GPV and MDPV dependoparvoviruses, which replicate autonomously without this dependance on a helper virus co-infection to replicate.31
Figure 1.

Taxonomy of AAV and a phylogenetic tree of the viruses belonging to the Dependoparvovirus genus
(A) Taxonomic position of AAV. (B) Phylogenetic tree of circulating dependoparvoviruses based on the alignment of NS1 protein sequences (retrieved from https://www.ncbi.nlm.nih.gov/), and adapted from Hildebrandt et al.25 The tree was rooted using an outgroup with two viruses, Bearded dragon parvovirus (genus: Dependoparvovirus; species: Dependoparvovirus squamate2) and snake parvovirus (genus: Dependoparvovirus; species: Dependoparvovirus squamate1). The colored dots at the branch nodes represent the bootstrap support values (see legend). Indicated with ⁎ or ⁎⁎ are viruses that are autonomous or suspected to be autonomous, respectively. Methodology: the NS1 protein sequences were retrieved from GenBank (accession numbers provided in Table S1) and analyzed in a Linux-based environment. MAFFT v7.520 was used to perform a multiple sequence alignment (MSA) (-maxiterate 1,000; -localpair).26 The alignment was trimmed with trimAI v1.5.0 (-gt 0.6 -w 3),27 and the tree was generated with ModelFinder in IQ-TREE v2.3.6 (-B 1,000).28 iTOL was used for visualization of the tree.29
At the functional level, AAV serotypes exhibit a high degree of modularity. The hairpin-shaped, inverted terminal repeats (ITRs) flanking the rest of the genome, have been shown to be interchangeable between different AAV serotypes, as have genes for the replication proteins, enabling cross-serotype replication and packaging in recombinant systems.35,36 Similarly, the assembly-activating protein (AAP) from AAV2 can support nucleolar targeting and capsid assembly of multiple other serotypes, underscoring strong functional conservation within the genus.37 This interchangeability has been exploited in recombinant AAV production platforms, in which Rep from one serotype can often be combined with ITRs and capsids from another serotype without loss of functionality.38,39 Notably, AAV serotype 5 (AAV5) forms an exception to this gene function exchange ability, probably because it represents the most divergent serotype within the AAV clade, both genetically and antigenically (Figure 1B).25,38
The evolutionary conserved features such as the modular genome organization hint toward a conserved replication strategy within the Dependovirus genus, despite the unique dependence of AAVs on helper virus functions. Understanding how this dependence emerged evolutionarily and how the helper functions can be substituted by diverse heterologous systems such as AdV, HSV, or baculovirus infection remains important for both understanding AAV biology as well as optimization of rAAV vector production.40
Virion structure and genome organization
Most of the reported AAV characterization is based on serotype AAV2, though there are at least thirteen identified AAV serotypes that naturally occur.41 The virions are nonenveloped, have an icosahedral shape, and a diameter around 25 nm (Figure 2A). The capsid has a T=1 symmetry and is composed of three viral proteins, VP1, VP2, and VP3, in a stoichiometric ratio of approximately 1:1:10, respectively.42 Without a helper virus, AAV can enter the cell, move through the cytoplasm, enter the nucleus and uncoat its genome.43 Here the genome persists predominantly in an episomal form as monomeric or concatenated double stranded DNA, or alternatively integrates at low frequency into the host genome.44 For wildtype (wt)AAV2 the integration frequency is approximately 1 in 1,000 infectious particles.45 Integration mainly occurs in the specific AAVS1 site in the human genome on chromosome nineteen (19q13.3), although it can also occur elsewhere.46,47,48,49 Only when essential helper virus genes are present, AAV replication is initiated.
Figure 2.

AAV virion structure and genome organization
(A) Purified rAAV preparations were stained with 2% uranyl acetate and imaged with transmission electron microscopy (TEM). A schematic view of the virion structure is included on the right. (B) Genome organization of the wt AAV2 genome. The virus has a linear single-stranded (ss) DNA genome with two major orfs, Rep and Cap, flanked by ITRs. Gene expression is mediated from four promoters (p5,p19, p40, and p81) from which mature transcripts originate via alternative splicing. Further protein diversity originates from alternative translation start codons.
The wtAAV2 genome consists of linear, ssDNA with a size of ∼4.7 kb (Figure 2B).50 Positive or negative genome strands are packaged with equal efficiency.2,51 The ends of the genome are 145 nt long ITR sequences that partially self-fold into hairpin-like structures.50 The ITRs are the only parts of the wt AAV genome that are retained when producing recombinant vectors. The ITRs are important for the initiation of DNA replication, as well as for providing packaging signals to facilitate genome encapsidation, and for mediating DNA integration into the host genome.52,53,54 The AAV genome contains two major coding regions: Rep and Cap. The p5 promoter generates an mRNA transcript that is translated into Rep78, and a shorter, spliced variant translating into Rep68. A non-spliced mRNA and a spliced variant produced from the p19 promoter translate into Rep52 and Rep40, respectively. The “major” Rep proteins (Rep78 and Rep68) are mostly involved in genome replication, while the “minor” proteins (Rep52 and Rep40) play a role in genome encapsidation.55 When producing rAAVs, supplying only one major and one minor Rep protein, typically Rep78 and Rep52, is sufficient for replication and encapsidation of genomes.56 The cap mRNA is transcribed from the p40 promoter, and gives rise to the three capsid proteins (VP1, VP2, and VP3), membrane-associated accessory protein (MAAP) and AAP. The individual capsid proteins VP1, VP2, and VP3 are translated from mRNAs produced via alternative RNA splicing and together assemble into the viral capsid. Translation of overlapping open reading frames (orfs) in the VP1 gene results in the expression of MAAP and AAP.57,58,59 The accessory protein MAAP was discovered most recently and serves as a viral egress factor aiding in release of AAV particles from the host cell.60,61 AAP stimulates capsid protein transport to the nucleolus, and is involved in capsid assembly.58 In addition, a minor coding region near the 3′ end of the cap orf encodes the X protein.50 Expression of the X gene is regulated by the p81 promoter, and this protein functions as an enhancer for DNA replication and virion production.62,63
Baculovirus-mediated rAAV production
Baculovirus biology and expression vector system
Baculoviruses are insect-infecting viruses that are commonly used for pest control purposes,64,65,66 and are applied in biotechnology for the expression of recombinant proteins, virus-like particle generation and production of rAAVs.10,67,68,69 Autographa californica multiple nucleopolyhedrovirus (AcMNPV) has been used as the basis for the development of the BEVS.70,71
AcMNPV, like other viruses in the Alphabaculovirus genus, produces two types of progeny virus: budded virus (BV) and occlusion-derived virus (ODV). BVs are generated during the “late phase” of infection by budding of nucleocapsids from the surface of infected cells, after which they facilitate the viral spread throughout an infected individual. While BVs contain a single nucleocapsid, the AcMNPV ODVs contain multiple nucleocapsids that are enveloped together ODVs are generated during the “very-late” phase of infection and are embedded in a crystalline matrix made from the viral polyhedrin protein to form so-called “polyhedra” or “occlusion bodies” (OBs) in the nuclei of infected cells. After the death of the infected insect, the OBs are released into the environment, where their integrity is retained by the polyhedrin crystalline matrix, which protects the progeny virus from degradation by environmental factors, such as temperature and to a certain extent, UV-light. Upon ingestion of OBs and the release of the ODVs in the insect’s midgut, the next individual becomes infected. The BV are also the type of virus needed for systemic infection of the insect cells in culture and are therefore essential for production of rAAV in insect cells.
AcMNPV has a circular, double-stranded (ds) DNA genome with a size of approximately 134 kbp.72 The individual BV virions are rod-shaped, contain a single supercoiled DNA molecule and are 250–300 nm in size.73 During an infection with wt AcMNPV, there are two very-late phase genes, p10 and polyhedrin (polh), expressed at high levels from their respective promoters. Whereas polh is the major structural component of OBs,74 P10 is a non-structural protein that facilitates their proper maturation.75,76 While P10 is not essential for OB formation, its absence results in structurally abnormal OBs.75,77 P10 and polh are neither required for BV production nor baculovirus propagation in insect cell culture.76,78 Both the p10 and polh promoters can therefore be used to drive high level expression of exogenous genes in cultured insect cells and are commonly employed in the BEVS.79
Through the incorporation of an antibiotic resistance gene and a bacterial origin of replication, the AcMNPV genome can be maintained in E. coli as a single-copy “bacmid” and easily edited with techniques, such as lambda red recombineering.80,81,82,83 Introduction of transgenes is nowadays typically done at the polh locus through attTn7-mediated transposition in E. coli or homologous recombination during co-transfection with a transfer plasmid on insect cells,84,85 though there are other options as well, including other loci for transposition, Gateway cloning, Cre-loxP site-specific recombination and Gibson assembly.86,87,88,89
rAAV production
Briefly: rAAV production in mammalian cells
During rAAV vector generation in mammalian cells the helper virus genes provide a multitude of functions. Mammalian helper viruses have been identified from the herpesvirus, AdV, papillomavirus families, as well as parvovirus human bocavirus 1 (HBoV1).1,90,91,92 The specifics of interactions between AAV and several helper viruses during production in mammalian cells is extensively reviewed in Meier et al.40 With AdV as an example of a helper virus, the minimal required AdV components are E1, E2A, VA RNA and E4 (Figure 3A).93,94,95,96,97 These essential helper functions mostly act to activate intrinsic AAV promoters for Rep and Cap expression (E1A, E2A), promote second strand synthesis (E1B, E4), aid in Rep mRNA splicing (E2A), and inhibit host cell immune responses and prevent AAV degradation (E4, VA RNA). Additionally, E1A drives the host cell into the DNA synthesis (S-) phase. Once in that phase, AAVs Rep78 can arrest the cell cycle.98,99 Commonly, rAAVs are produced in human embryonic kidney 293 cells (HEK293) through triple co-transfection with plasmids encoding the E2A, VA RNA, and E4 helper functions, AAV Rep and Cap, and the ITR-GOI (Figure 3A). Upon their generation, HEK293 cells were transformed with sheared AdV5 DNA and made to express the E1 gene, therefore it is not required to supply E1 in a helper plasmid when using these cells.100
Figure 3.

Overview of rAAV production strategies on mammalian and insect cells
(A) Production in mammalian (HEK293) cells through a transient co-transfection with a GOI plasmid, Rep-Cap plasmid and plasmid containing AdV helper genes. (B) Production in (Sf9) insect cells with recombinant baculoviruses using a triple, double or single baculovirus infection to produce rAAV. (HEK293: Human embryonic kidney cells; ITR: inverted terminal repeat; GOI: gene of interest; Sf9 = Spodoptera frugiperda 9; hr: homologous repeat; polh: polyhedrin)
HSV-1 is another human virus that can be used as a helper virus for rAAV vector production in HEK293 cells.4 The HSV-1 helicase-primase complex, consisting of UL5, UL8, and UL52, and ICP8 protein (UL29) are all essential for rAAV replication.90 These proteins functionally replace AdV DNA replication helper functions by binding to Rep78 and AAV ssDNA, hence promoting AAV DNA replication.101 Although not essential, the HSV-1 immediate-early transcriptional regulators ICP0 (RL2) and ICP4 (RS1) were found to enhance AAV Rep and Cap expression.102 HSV-1 DNA polymerase activity is not required for AAV production, indicating that HSV-1 supports AAV replication primarily by providing replication-supportive and regulatory functions rather than directly performing genome synthesis.90 With HSV-1 as a helper virus, AAV2 replication was established to mostly takes place in the S/gap 2 (G2) phase.103
Production in insect cells
Production of rAAV in insect cells differs fundamentally from mammalian platforms, as AAV is not known to naturally infect insects and was therefore not initially expected to be able to replicate in this environment. To circumvent the expected inactivity or suboptimal activity of native AAV promoters when producing AAVs with the BEVS, the Rep and Cap cassettes were cloned downstream of baculoviral promoters. The first demonstration of functional AAV Cap expression in insect cells was reported by Ruffing et al.104 who produced the three VP1, VP2, and VP3 from polh promoter copies present on promoters in three separate baculoviruses and demonstrated empty capsid assembly in Sf9 cells. While the suboptimal VP stoichiometry obtained with this method also led to aggregation of unassembled VP proteins, the study did establish that AAV capsid assembly is possible in insect cells.
A decade later, the first production of genome-containing rAAV particles using the BEVS was published (Figure 3B).10 In the study, Rep, Cap, and ITR-GOI were supplied via three separate baculoviruses. This work demonstrated functional Rep activity in insect cells for the first time. Because native AAV promoters and introns are poorly functional in insect cells, Rep78 and Rep52 were expressed from a truncated AcMNPV immediate-early 1 (IE1) and the polh promoter, respectively, while Cap expression was driven by a second copy of the polh promoter and regulated through non-canonical start codons to enable “leaky scanning” to allow expression of all three VPs.105,106 Genetic stability of the recombinant baculovirus was not assessed in the original study, but subsequent work revealed Rep gene instability after two to four passages, likely due to sequence identity between Rep78 and Rep52 that may have facilitated intramolecular homologous recombination.107,108 Despite drawbacks, including empty capsid formation and the requirement for triple co-infection, the study by Urabe et al.10 established BEVS as a promising platform for rAAV production, prompting further optimization in subsequent years.
Key improvements to the BEVS-rAAV production platform reduced the number of required baculoviruses from three to two by co-expressing Rep and Cap from a single baculovirus (Figure 3B).11,12 Chen addressed instability and poor expression associated with the native Rep intron in insect cells through introduction of artificial introns into the Rep and Cap coding sequences, enabling expression of Rep78 and Rep52 from a single orf while preventing large homologous repeats.12 This design showed genetic stability through passage 5. Smith et al.11 instead employed a bifunctional mRNA strategy based on leaky scanning to express Rep78 and Rep52 by extending on a mechanism natively applied to Cap expression in wtAAV. This recombinant baculovirus maintained consistent Rep and Cap expression through passage 6, after which expression declined. Together, these studies demonstrated improved genetic stability, higher rAAV titers, and reduced system complexity, all of which significantly enhanced the feasibility of large-scale rAAV production with the BEVS.
Although the reduction to only two baculoviruses improved robustness, further simplification was pursued to facilitate low-MOI infection strategies, which would reduce virus input, stock virus passaging cycles, and production costs. Wu et al.109 first demonstrated rAAV production from a single baculovirus by combining Rep, Cap, and an ITR-GOI within one vector using a leaky scanning strategy (Figure 3B). However, genetic instability emerged after passage 5. Galibert et al.110 subsequently reported a single-baculovirus system with Rep and Cap expressed from polh and p10 promoters, respectively, and the transgene cassette (ITR-GOI) integrated at a separate locus in the baculovirus genome, demonstrating rAAV production in shake flask and bioreactor settings. In parallel, alternative approaches based on stable producer or packaging cell lines were developed, most notably the “OneBac” system, in which Cap and Rep are inducibly expressed and rAAV production is achieved by infection with a single baculovirus carrying the ITR-GOI.16,18,111
Importance of host cell environment
Insect cells infected with recombinant baculovirus provide an altered intracellular environment for rAAV replication compared to production on mammalian cells, yet the system still supports Cap and Rep expression, ITR-dependent replication/processing, and capsid assembly. Apparently, baculovirus and/or insect-cell derived factors appear to substitute for adenoviral helper functions, although the exact identities and mechanisms are incompletely mapped. Insect cell lines used for the production of recombinant proteins with the BEVS are commonly derived from Spodoptera frugiperda (e.g., Sf9, Sf21) or Trichoplusia ni (Hi5). While the application of these cell lines for the production of therapeutics has been demonstrated,112 Sf9 cells are generally favored and more widely applied, mainly due to their increased capacity of progeny baculovirus production compared to Hi5,113 and increased tolerance to culture condition variations compared to Sf21.114 The use of Hi5 cells for rAAV production has been documented once before, where no significant differences in vector yields were reported in a comparison between Sf9 and Hi5 cells.115 In this review we focus on rAAV production in Sf9 cells, since it is the most predominantly used insect cell line for this purpose.116
Although unexpected due to the stark differences between mammalian and insect cells, the activity of native AAV promoters has been detected during the attempted production of wtAAV2 in insect cells.117 In the study, the full genome of AAV2 was inserted into a bacmid, which was used to transfect Sf9 cells. Apparent native p5 and p19 rep promoter activity in insect cells caused excision of the transgene sequence from the baculovirus during earlier phases of infection. This observation provides evidence that baculovirus infection creates an environment permissive for at least partial activation of AAV regulatory elements. This supports the broader notion that baculovirus infection supplies helper-like functions for AAV in insect cells, not only by remodeling host DNA replication pathways or expressing Cap and Rep from baculoviral promoters, but also by enabling activity of AAV cis-regulatory elements that would otherwise be expected to be inactive.
AAV is a mammalian virus and naturally replicates in vertebrate hosts at a temperature around 37°C. In contrast, recombinant AAV production using the baculovirus-insect cell system is routinely performed at 27–28 °C, the optimal temperature for baculovirus infection and insect cell metabolism.118,119 This apparent temperature discrepancy likely reflects the permissive replication environment created by baculovirus infection, which drives strong expression of AAV components and sustains active host DNA metabolism at the lower temperatures.
As mentioned before, Rep78 itself can modulate the cellular state to arrest the cell cycle at the S-phase, although it requires helper functions that induce the S-phase in the first place.98 Despite Rep78 causing a cell cycle arrest here, AAV genome replication is reported to increase when the cell cycle is arrested in the mitotic (M) or gap 2 (G2) phase.120,121 Baculoviruses are known to induce extensive host cell reprogramming to support viral DNA replication, and they can induce and arrest the cell cycle in the M, G2 or S-phase.122,123 Baculovirus infection drives infected insect cells into a replication-competent state characterized by sustained activity of host DNA replication and repair pathways.124,125 This baculovirus-induced cellular state likely provides the replication machinery exploited by AAV Rep to drive vector genome amplification, functionally substituting for adenoviral E1A-dependent host activation. It remains unclear which baculovirus gene products or infection-induced host responses are specifically required for AAV replication, and whether helper activity arises from discrete baculovirus factors or from general adjustment of the host replication environment.
Efficient AAV DNA replication requires host replication factors, including DNA polymerase δ, cellular replication factor C (RFC), proliferating cell nuclear antigen (PCNA), and the minichromosomal maintenance (MCM) helicase complex, together with the viral Rep protein.126 Depletion of MCM components or DNA polymerase δ strongly impairs AAV genome replication, underscoring AAV’s reliance on the host replication machinery.126 PCNA is conserved among eukaryotes and is an essential processivity factor for DNA replication, as well as involved in cell cycle control, DNA repair and chromatin remodeling.127 In mammalian cells, viral helper functions benefit AAV by upregulating these host replication factors.40,128,129 In baculovirus-mediated rAAV production, no direct homologs of adenoviral helper genes have been identified. However, baculoviruses do encode for a PCNA homolog (ac49),130,131 as well as a DNA polymerase (ac65) belonging to the same B-family type of polymerases where DNA polymerase δ belongs to.132 Possibly, these baculovirus homologs are substituting for the AdV helper functions that recruit these factors during production on mammalian cells.
Lastly, to point out the key role the host cell environment plays, there are reports of AAV replication occurring in mammalian cells without a helper virus or helper virus genes present, although this required extreme changes in cellular environment. Yakobson et al.133 demonstrated successful AAV2 replication in Chinese hamster (OD4) cells after inducing DNA-damage through pre-treatment with hydroxyurea, polyamine depletion or mitotic detachment. Additionally, induction of DNA-damage through irradiation with UV light had the same effect.134 The treatments caused an arrest in the S-phase for the majority of the cells, which is when the cellular environment is optimal for most autonomous parvoviruses to replicate.135 Despite only detecting AAV replication in few cells of the treated cell population, the findings do highlight the importance of the correct cellular environment during AAV replication. Whether this approach could have the same effect in insect cells remains to be determined.
Plausible baculovirus-AAV interactions: Candidate baculovirus genes
In mammalian systems, AAV replication strictly depends on adenoviral helper functions that modulate host transcription, DNA replication, and DNA damage responses (DDRs). Similar to the production with mammalian helper viruses, replication of AAV in the BEVS is unlikely driven by a single helper factor, but permitted by a modified cellular state induced by baculovirus infection.136 The mammalian helper viruses and baculoviruses are evolutionary distinct, therefore no direct sequence homologs of AdV or HSV helper genes exist in the baculovirus. However, identifying functional homologs that recreate an equivalent nuclear environment is a rational strategy (Table 1). When producing rAAVs with the BEVS, some helper functions aiding in the activation of intrinsic AAV promoters can be circumvented by driving Rep and Cap expression with baculoviral promoters as explained before. In this section, we compare functional homology between AdV, HSV, and baculoviral helper functions in the context of AAV replication without the use of baculovirus promoters for Rep and Cap expression, for a more complete overview. The proposed candidate baculoviral helper genes are summarized in Table 1, and discussed in the following sections.
Table 1.
Putative baculovirus helper genes for AAV replication based on predicted functional homology with AdV or HSV helper viruses
| Helper function | Mammalian virus helper genes or proteins | Putative baculovirus functional homologs |
|---|---|---|
| Transcriptional activation/nuclear reprogramming | E1A (AdV); ICP4, ICP0 (HSV) | IE-1 (ac147), IE-2 (ac151), PE38 (ac153) |
| Replication-permissive host state/cell-cycle coordination | E1A (AdV) | PCNA (ac49) |
| DNA unwinding (helicase activity) | UL5/UL8/UL52 (HSV) | p143 helicase (ac95) |
| ssDNA binding and stabilization | E2A (AdV); ICP8/UL29 (HSV) | LEF-3 (ac131) |
| DNA priming/primase activity | Host Pol α recruitment (AdV); UL52 (HSV) | LEF-1 (ac14), LEF-2 (ac58) |
| DNA processing/recombination | E4 gene products (AdV); UL12 (HSV) | ALK-EXO (ac133) |
| Late-stage genome handling/packaging environment | UL25/UL32 (HSV) | VLF-1 (ac77) |
| DNA damage response modulation | E4orf6/E1B55K (AdV); ICP0 (HSV) | LEF-7 (ac96) |
| Stress response/translation competence (PKR pathway) | VA RNA (AdV); US11 (HSV) | PK2 (ac123) |
AdV, adenovirus; HSV, herpes simplex virus; IE, immediate early; ac, AcMNPV open reading frame; LEF, late expression factor; ALK-EXO, alkaline exonuclease; VLF-1, very-late factor 1; PKR, protein kinase R; PK, protein kinase.
Transcriptional reprogramming
A common feature of AAV helper viruses is the functioning of early regulatory proteins that reprogram host transcription. In AdV, this role is fulfilled by E1A, while in HSV it is mediated primarily by ICP0, ICP4 and ICP22.93,137 Baculoviruses encode for comparable transcriptional regulators, including immediate-early 1 (IE-1), IE-2, and PE38, which together mediate early and early to late viral gene expression and broadly remodel host transcriptional activity.138,139 IE-1 is the major immediate-early transactivator, plays a crucial role in the switch to replication, and is essential for initiating the baculovirus transcriptional cascade, while IE-2 and PE38 further modulate viral and host gene expression.140 Although these proteins share no sequence homology with AdV or HSV regulators, their ability to establish a virus-dominated transcriptional environment suggests functional equivalence that may indirectly enhance AAV Rep and Cap expression.
DNA replication support
AdV E2A is a ssDNA-binding protein, which enhances the stability and processivity of the AAV genome.94 With HSV as a helper virus, the helicase-primase complex (UL5/UL8/UL52) and ICP8 perform analogous roles.101 Baculovirus encodes a set of core DNA replication proteins that may functionally parallel these activities. These include the p143 helicase, the late expression factor 1 (LEF-1) and LEF-2 primase complex, and the LEF-3 ssDNA-binding protein.73 LEF-1 is a DNA primase essential for baculovirus DNA synthesis, and works with LEF-2 acting as a cofactor.141 LEF-3 binds to and stabilizes ssDNA replication intermediates.142 Together, these factors may support AAV replication by stabilizing Rep-generated DNA structures and through primase activity. Additionally, baculovirus encode a PCNA, a delayed-early gene product involved in DNA synthesis and repair, as well as cell-cycle coordination.143 This protein may further support a cellular environment conducive to AAV genome replication.
DNA processing and genome maturation
Beyond replication, helper viruses provide DNA processing activities that facilitate genome maturation. In AdV, E4 gene products promote AAV second strand synthesis and RNA processing,6 and HSV encodes an alkaline exonuclease (UL12), which processes DNA replication intermediates.102 Baculovirus encodes an alkaline exonuclease (ALK-EXO) involved in viral DNA recombination and processing, and it is a close functional analog to the compared proteins in AdV and HSV, representing a strong candidate for involvement in AAV genome processing through circularization and/or maturation.144
Another candidate is very-late expression factor 1 (VLF-1), which is a DNA-binding protein required for very late gene expression and viral DNA packaging.145,146 Although primarily characterized as a transcription factor, the DNA binding properties of VLF-1 and its role in genome handling raise the possibility that it modulates replication or genome organization in ways that could influence AAV packaging efficiency.145,147
Modulation of host antiviral responses
Manipulation of the cellular DDR is an important helper function of mammalian AAV helper viruses. AdV actively suppresses DDR signaling through E4orf6/E1B55K, while HSV-1 employs ICP0 to disrupt intrinsic antiviral defenses.148 Additionally, AdV VA RNAs also aid in mediating host defenses through inhibition of the antiviral protein kinase R (PKR) pathway.149 Baculovirus infection effectively manipulates the host cells’ DDR response to promote viral DNA replication and propagation through the activity of LEF-7.150,151 Additionally, baculovirus encodes a protein kinase 2 (PK2), which is involved in evading PKR-mediated protein shut off mechanisms and mitigating stress-induced antiviral responses, thereby supporting viral DNA replication and protein synthesis.152,153
Suggested experimental approach to verifying interactions
Transcriptional and proteomic time course experiments
Transcriptomics has been performed on the Sf9 cells during production of rAAV with the BEVS before with intent to identify insect cell population variability during production and its effect on product yield and quality.154,155 A transcriptional and proteomic time-course analysis can also support identification of baculovirus helper functions by temporally linking baculovirus gene expression with stages of AAV replication and packaging. Baculovirus infection follows a tightly regulated cascade of immediate-early, early, late, and very-late gene expression, each associated with specific cellular processes such as DNA replication, virus transcriptional control, and virion assembly.79,156 RNA-seq performed at different hours post-infection allows for the simultaneous quantification of baculovirus, AAV, and host transcripts (Figure 4A). By doing so, genes whose expression or protein abundance precedes or coincides with, for example Rep accumulation, AAV and baculovirus genome replication, capsid synthesis or virion assembly, can be investigated as candidate helper factors. Integration of (quantitative) proteomics data may be particularly helpful, as it captures post-transcriptional regulation and protein dynamics that are not reflected at the RNA level. This addition could enable discrimination between genes that are merely co-expressed and those whose gene products that interact with AAV gene expression and influence replication.
Figure 4.

Suggested experimental approaches for identifying baculovirus and (r)AAV interactions
(A) Through infection of Sf9 cells with baculoviruses that contain or lack (some or all) AAV transgenes and harvesting RNA samples at separate timepoints for RNA-sequencing, differentially expressed genes can be identified. These differential expressions can point into the direction of interactions between AAV, baculovirus and Sf9 cells. (B) By generating baculovirus deletion mutants, the impact of specific deletions on the replication and generation of rAAV can be tested. (C) TurboID can be fused to an AAV (e.g., Rep78) or baculovirus protein to detect proteins that are in close proximity and may be interacting (in)directly with the labeled protein. Upon biotin addition, ATP and biotin are converted by the TurboID enzyme into biotin-AMP, which covalently labels proximal endogenous proteins. These can be pulled down with streptavidin beads in an affinity purification assay, and subsequently identified mass spectrometry. (hpi, hours post infection; cDNA, complementary DNA)
Functional necessity screen: Baculovirus gene knockouts
To directly assess which baculovirus genes are functionally required for efficient rAAV replication and packaging, targeted baculovirus gene deletion mutants can be generated and evaluated for their ability to support AAV production in insect cells such as Sf9 (Figure 4B). Comparing rAAV yields, genome replication, and capsid assembly across individual deletion mutants would provide strong evidence for helper activity.
A major limitation of this approach is that many baculovirus genes are essential for baculoviral DNA replication, late gene expression, or BV formation, complicating interpretation when deletions compromise baculovirus viability itself.125,157,158 To address this, conditional strategies may be employed, such as inducible or partial knockdowns, or the use of complementing insect cell lines that stably express the candidate baculovirus gene. This “from-the-ground-up” complementation approach can decouple the role of a gene in baculovirus propagation from its potential helper function in AAV biology.
Generating baculovirus deletion mutants with defects in defined phases of infection can be a useful strategy to investigate whether AAV genome replication and capsid formation depend on specific baculoviral functions. Examples could be the deletion of lef-1 (ac14) or vlf-1 (ac77).145,159 The lef-1 gene encodes a DNA primase required for baculovirus DNA replication, and deletion results in viruses that fail to progress into late and very late phases of infection.160 Deletion of vlf-1 abolishes very late gene expression without preventing earlier stages of viral replication.146 By supplying the AAV Rep, Cap and ITR-GOI in trans with (non-)baculoviral promoters unaffected by vlf-1 impairment, the impact of specific baculoviral gene expression defects on AAV genome replication and capsid formation can be assessed with a reduced dependence on baculovirus late or very late gene expression. Rep-dependent AAV genome replication can be quantified by qPCR, while capsid assembly can be monitored using an ELISA assay.
Rescue experiments are critical to validate specificity. If the deletion of a candidate gene reduces rAAV yield or alters replication phenotypes, re-introduction of the gene via a helper baculovirus or plasmid should restore AAV production. Such genetic complementation strengthens causal inference and helps rule out indirect effects stemming from unintended baculovirus defects.
Proximity labeling
Proximity-dependent labeling approaches offer a powerful, unbiased strategy to identify physical and spatial associations between AAV proteins and baculovirus or host cell factors (Figure 4C). Fusion of proximity labels, for example with BioID or (split-)TurboID, to AAV proteins would enable biotinylation of neighboring proteins during active infection.161,162,163,164 After affinity purification, mass spectrometry needs to be performed to identify the interacting proteins. This approach is particularly attractive for application in the BEVS-rAAV system, where transient or weak interactions may be difficult to capture by conventional co-immunoprecipitation methods. Proximity labeling can reveal candidate helper proteins involved in replication complex assembly, genome packaging, nuclear trafficking, or capsid maturation. Complementary to the proximity labeling, other localization studies using fluorescence microscopy or (cryo-)electron microscopy could further refine spatial context, for example by mapping Rep-associated replication compartments relative to baculovirus replication complexes.
Conclusions and future prospects
rAAV vectors have a promising therapeutic potential for many genetic disorders. Since its first description in 1983, the BEVS has been developed into a dependable biotechnological platform for the production of various recombinant proteins.71,79 Despite early initial descriptions of rAAV production with the BEVS in 2002, it took several years of development for the application to experience the process development and optimization needed to convert into the promising platform it has become today.10,165 With rAAV making up for approximately a third of the vectors used in clinical trials for in vivo gene therapy,166 and the BEVS being continually evolved for vector production, gaps in the fundamental understanding of the interaction between these two viruses became more apparent. It is unclear which baculovirus genes are required, supportive, or dispensable for directly or indirectly supporting (r)AAV replication, whether AAV genome replication centers spatially or temporally overlap with baculoviral replication factories, and which steps in the AAV life cycle constitute the principal bottlenecks in BEVS. Moreover, the role of insect host cell factors and the effect of different post-translational modifications occurring during production in insect cells on the in vivo vector potency are important points of study.167 These unknowns are reflected in persistent challenges such as variable genome packaging efficiencies, serotype-dependent productivity, and empty capsid formation percentages.168,169,170,171
Addressing these questions will advance our mechanistic understanding of the helper virus complementation by the baculovirus, while also enabling the rational engineering of improved BEVS-based rAAV production systems. The determination of baculovirus helper functions may ultimately allow the development of minimal helper modules or reduced baculovirus genomes, aiding to enhance yield, consistency, and product quality. The application of synthetic biology for the minimization of baculovirus genomes provides an opportunity to tailor baculovirus vectors for improved helper function while reducing unnecessary viral burden.172,173,174 Multi-omics approaches, combining transcriptomics, proteomics, and metabolomics, can be applied to identify insect cell host factors and baculovirus gene products that influence (r)AAV genome replication, genome packaging, and capsid assembly, thereby providing new targets for producer cell line and process engineering.154,155,175 Together, these approaches may enable the transition from empirical optimization toward rational engineering of BEVS platforms for rAAV production.
Acknowledgments
This work was funded by VectorY Therapeutics. We thank Jelmer Vroom from WEMC for the TEM images, Hans Bastiaansen for assistance in obtaining the samples for TEM, and Astrid Bryon for providing the basis of the script used for the phylogeny analysis.
Author contributions
L.A.d.J. conceived the research, reviewed literature, wrote and edited the manuscript. M.M.v.O. acquired the funding, wrote and edited the manuscript. G.P.P. contributed to the conception of the research, supervised the project, wrote and edited the manuscript.
Declaration of interests
The authors declare no competing interests.
Footnotes
Supplemental information can be found online at https://doi.org/10.1016/j.omta.2026.201876.
Supplemental information
References
- 1.Atchison R.W., Casto B.C., Hammon W.M. Adenovirus-associated defective virus particles. Science. 1965;149:754–756. doi: 10.1126/science.149.3685.754. [DOI] [PubMed] [Google Scholar]
- 2.Gerry H.W., Kelly T.J., Bern K.I. Arrangement of nucleotide sequences in adeno-associated virus DNA. J. Mol. Biol. 1973;79:207–226. doi: 10.1016/0022-2836(73)90001-6. [DOI] [PubMed] [Google Scholar]
- 3.Ito M., Suzuki E. Adeno-associated satellite virus growth supported by a temperature-sensitive mutant of human adenovirus. J. Gen. Virol. 1970;9:243–245. doi: 10.1099/0022-1317-9-3-243. [DOI] [PubMed] [Google Scholar]
- 4.Buller R.M.L., Janik J.E., Sebring E.D., Rose J.A. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication isotopic labeling and analysis of nucleic acids. J. Virol. 1981;40:241–247. doi: 10.1128/JVI.40.1.241-247.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Myers M.W., Laughlin C.A., Jay F.T., Carter B.J. Adenovirus helper function for growth of adeno-associated virus: Effect of temperature-sensitive mutations in adenovirus early gene region 2. J. Virol. 1980;35:65–75. doi: 10.1128/jvi.35.1.65-75.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Xiao X., Li J., Samulski R.J., Center G.T. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 1998;72:2224–2232. doi: 10.1128/JVI.72.3.2224-2232.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Collaco R.F., Cao X., Trempe J.P. A helper virus-free packaging system for recombinant adeno-associated virus vectors. Gene. 1999;238:397–405. doi: 10.1016/S0378-1119(99)00347-9. [DOI] [PubMed] [Google Scholar]
- 8.Lee Z., Lu M., Irfanullah E., Soukup M., Hu W.S. Construction of an rAAV Producer Cell Line through Synthetic Biology. ACS Synth. Biol. 2022;11:3285–3295. doi: 10.1021/acssynbio.2c00207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Jalšić L., Lytvyn V., Elahi S.M., Hrapovic S., Nassoury N., Chahal P.S., Gaillet B., Gilbert R. Inducible HEK293 AAV packaging cell lines expressing Rep proteins. Mol. Ther. Methods Clin. Dev. 2023;30:259–275. doi: 10.1016/j.omtm.2023.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Urabe M., Ding C., Kotin R.M. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 2002;13:1935–1943. doi: 10.1089/10430340260355347. [DOI] [PubMed] [Google Scholar]
- 11.Smith R.H., Levy J.R., Kotin R.M. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol. Ther. 2009;17:1888–1896. doi: 10.1038/mt.2009.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chen H. Intron splicing-mediated expression of AAV rep and cap genes and production of AAV vectors in insect cells. Mol. Ther. 2008;16:924–930. doi: 10.1038/mt.2008.35. [DOI] [PubMed] [Google Scholar]
- 13.Ylä-Herttuala S. Endgame: Glybera finally recommended for approval as the first gene therapy drug in the European union. Mol. Ther. 2012;20:1831–1832. doi: 10.1038/mt.2012.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Anguela X.M., High K.A. Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec. Blood Adv. 2024;8:1796–1803. doi: 10.1182/bloodadvances.2023010511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Samelson-Jones B.J., Small J.C., George L.A. Roctavian gene therapy for hemophilia A. Blood Adv. 2024;8:5179–5189. doi: 10.1182/bloodadvances.2023011847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Mietzsch M., Casteleyn V., Weger S., Zolotukhin S., Heilbronn R. OneBac 2.0: Sf9 cell lines for production of AAV5 vectors with enhanced infectivity and minimal encapsidation of foreign DNA. Hum. Gene Ther. 2015;26:688–697. doi: 10.1089/hum.2015.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Mietzsch M., Grasse S., Zurawski C., Weger S., Bennett A., Agbandje-Mckenna M., Muzyczka N., Zolotukhin S., Heilbronn R. OneBac: Platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. Hum. Gene Ther. 2014;25:212–222. doi: 10.1089/hum.2013.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Moreno F., Lip F., Rojas H., Anggakusuma Anggakusuma. Development of an insect cell-based adeno-associated virus packaging cell line employing advanced Rep gene expression control system. Mol. Ther. Methods Clin. Dev. 2022;27:391–403. doi: 10.1016/j.omtm.2022.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Pénzes J.J., Söderlund-Venermo M., Canuti M., Eis-Hübinger A.M., Hughes J., Cotmore S.F., Harrach B. Reorganizing the family Parvoviridae: a revised taxonomy independent of the canonical approach based on host association. Arch. Virol. 2020;165:2133–2146. doi: 10.1007/s00705-020-04632-4. [DOI] [PubMed] [Google Scholar]
- 20.Tattersall P., Ward D.C. Rolling hairpin model for replication of parvovirus and linear chromosomal DNA. Nature. 1976;263:106–109. doi: 10.1038/263106a0. [DOI] [PubMed] [Google Scholar]
- 21.Konopa G., Barańska S., Wegrzyn A., Wegrzyn G. Bacteriophage and host mutants causing the rolling-circle λ DNA replication early after infection. FEBS Lett. 2000;472:217–220. doi: 10.1016/S0014-5793(00)01451-4. [DOI] [PubMed] [Google Scholar]
- 22.Bonnamy M., Blanc S., Michalakis Y. Replication mechanisms of circular ssDNA plant viruses and their potential implication in viral gene expression regulation. mBio. 2023;14 doi: 10.1128/mbio.01692-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cotmore S.F., Tattersall P. Parvoviruses: Small does not mean simple. Annu. Rev. Virol. 2014;1:517–537. doi: 10.1146/annurev-virology-031413-085444. [DOI] [PubMed] [Google Scholar]
- 24.Cotmore S.F., Agbandje-McKenna M., Canuti M., Chiorini J.A., Eis-Hubinger A.M., Hughes J., Mietzsch M., Modha S., Ogliastro M., Pénzes J.J., et al. ICTV virus taxonomy profile: Parvoviridae. J. Gen. Virol. 2019;100:367–368. doi: 10.1099/JGV.0.001212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hildebrandt E., Penzes J.J., Gifford R.J., Agbandje-Mckenna M., Kotin R.M. Evolution of dependoparvoviruses across geological timescales—implications for design of AAV-based gene therapy vectors. Virus Evol. 2020;6 doi: 10.1093/ve/veaa043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Katoh K., Standley D.M. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 2013;30:772–780. doi: 10.1093/molbev/mst010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Capella-Gutiérrez S., Silla-Martínez J.M., Gabaldón T. trimAl: A tool for automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics. 2009;25:1972–1973. doi: 10.1093/bioinformatics/btp348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Nguyen L.T., Schmidt H.A., Von Haeseler A., Minh B.Q. IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 2015;32:268–274. doi: 10.1093/molbev/msu300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Letunic I., Bork P. Interactive Tree of Life (iTOL) v6: Recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 2024;52:W78–W82. doi: 10.1093/nar/gkae268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Smith D.H., Ward P., Linden R.M. Comparative characterization of rep proteins from the helper-dependent adeno-associated virus type 2 and the autonomous goose parvovirus. J. Virol. 1999;73:2930–2937. doi: 10.1128/jvi.73.4.2930-2937.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zádori Z., Stefancsik R., Rauch T., Kisary J. Analysis of the Complete Nucleotide Sequences of Goose and Muscovy Duck Parvoviruses Indidates Common Ancestral Origin with Adeno-Associated Virus 2. Virology. 1995;212:562–573. doi: 10.1006/viro.1995.1514. [DOI] [PubMed] [Google Scholar]
- 32.Brown K.E., Green S.W., Young N.S. Goose Parvovirus - An autonomous Member of the Dependovirus Genus? Virology. 1995;210:283–291. doi: 10.1006/viro.1995.1345. [DOI] [PubMed] [Google Scholar]
- 33.Lukashov V.V., Goudsmit J. Evolutionary Relationships among Parvoviruses: Virus-Host Coevolution among Autonomous Primate Parvoviruses and Links between Adeno-Associated and Avian Parvoviruses. J. Virol. 2001;75:2729–2740. doi: 10.1128/jvi.75.6.2729-2740.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ferrari F.K., Samulski T., Shenk T., Samulski R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 1996;70:3227–3234. doi: 10.1128/jvi.70.5.3227-3234.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Choi V.W., McCarty D.M., Samulski R.J. AAV hybrid serotypes: improved vectors for gene delivery. Curr. Gene Ther. 2005;5:299–310. doi: 10.2174/1566523054064968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Grimm D., Pandey K., Nakai H., Storm T.A., Kay M.A. Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. J. Virol. 2006;80:426–439. doi: 10.1128/jvi.80.1.426-439.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Sonntag F., Köther K., Schmidt K., Weghofer M., Raupp C., Nieto K., Kuck A., Gerlach B., Böttcher B., Müller O.J., et al. The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes. J. Virol. 2011;85:12686–12697. doi: 10.1128/jvi.05359-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Chiorini J.A., Afione S., Kotin R.M. Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J. Virol. 1999;73:4293–4298. doi: 10.1128/jvi.73.5.4293-4298.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mietzsch M., Eddington C., Jose A., Hsi J., Chipman P., Henley T., Choudhry M., McKenna R., Agbandje-McKenna M. Improved genome packaging efficiency of adeno-associated virus vectors using Rep hybrids. J. Virol. 2021;95:e0077321. doi: 10.1128/jvi.00773-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Meier A.F., Fraefel C., Seyffert M. The interplay between adeno-associated virus and its helper viruses. Viruses. 2020;12 doi: 10.3390/v12060662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Issa S.S., Shaimardanova A.A., Solovyeva V.V., Rizvanov A.A. Various AAV serotypes and their applications in gene therapy: An overview. Cells. 2023;12 doi: 10.3390/cells12050785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Johnson F.B., Ozer H.L., Hoggan M.D. Structural Proteins of Adenovirus-Associated Virus Type 3. J. Virol. 1971;8:860–863. doi: 10.1128/JVI.8.6.860-863.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Xiao W., Warrington K.H., Hearing P., Hughes J., Muzyczka N. Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2. J. Virol. 2002;76:11505–11517. doi: 10.1128/jvi.76.22.11505-11517.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Penaud-Budloo M., Le Guiner C., Nowrouzi A., Toromanoff A., Chérel Y., Chenuaud P., Schmidt M., von Kalle C., Rolling F., Moullier P., Snyder R.O. Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle. J. Virol. 2008;82:7875–7885. doi: 10.1128/jvi.00649-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hüser D., Weger S., Heilbronn R. Kinetics and Frequency of Adeno-Associated Virus Site-Specific Integration into Human Chromosome 19 Monitored by Quantitative Real-Time PCR. J. Virol. 2002;76:7554–7559. doi: 10.1128/jvi.76.15.7554-7559.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Samulski R.J., Zhu X., Xiao X., Brook J.D., Housman D.E., Epstein N., Hunter L.A. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 1991;10:3941–3950. doi: 10.1002/j.1460-2075.1991.tb04964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kotin R.M., Linden R.M., Berns K.I. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 1992;11:5071–5078. doi: 10.1002/j.1460-2075.1992.tb05614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Giraud C., Winocour E., Berns K.I. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. USA. 1994;91:10039–10043. doi: 10.1073/pnas.91.21.10039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kotin R.M., Siniscalco M., Samulski R.J., Zhu X.D., Hunter L., Laughlin C.A., McLaughlin S., Muzyczka N., Rocchi M., Berns K.I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA. 1990;87:2211–2215. doi: 10.1073/pnas.87.6.2211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Srivastava A., Lusby E.W., Berns K.I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 1983;45:555–564. doi: 10.1128/jvi.45.2.555-564.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Mayor H.D., Torikai K., Melnick J.L., Mandel M. Plus and minus single-stranded DNA separately encapsidated in adeno-associated satellite virions. Science. 1969;166:1280–1282. doi: 10.1126/science.166.3910.1280. [DOI] [PubMed] [Google Scholar]
- 52.Snyder R.O., Im D.S., Ni T., Xiao X., Samulski R.J., Muzyczka N. Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J. Virol. 1993;67:6096–6104. doi: 10.1128/jvi.67.10.6096-6104.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.McCarty D.M., Pereira D.J., Zolotukhin I., Zhou X., Ryan J.H., Muzyczka N. Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J. Virol. 1994;68:4988–4997. doi: 10.1128/jvi.68.8.4988-4997.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Wang X.S., Ponnazhagan S., Srivastava A. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions. J. Virol. 1996;70:1668–1677. doi: 10.1128/jvi.70.3.1668-1677.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Daya S., Berns K.I. Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 2008;21:583–593. doi: 10.1128/CMR.00008-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Hölscher C., Kleinschmidt J.A., Bürkle A. High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant. J. Virol. 1995;69:6880–6885. doi: 10.1128/JVI.68.11.7169-7177.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Ogden P.J., Kelsic E.D., Sinai S., Church G.M. Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design. Science (1979) 2019;366:1139–1143. doi: 10.1126/science.aaw2900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sonntag F., Schmidt K., Kleinschmidt J.A. A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl. Acad. Sci. USA. 2010;107:10220–10225. doi: 10.1073/pnas.1001673107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kuz C.A., McFarlin S., Qiu J. The Expression and Function of the Small Nonstructural Proteins of Adeno-Associated Viruses (AAVs) Viruses. 2024;16:1215. doi: 10.3390/v16081215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Elmore Z.C., Patrick Havlik L., Oh D.K., Anderson L., Daaboul G., Devlin G.W., Vincent H.A., Asokan A. The membrane associated accessory protein is an adeno-associated viral egress factor. Nat. Commun. 2021;12 doi: 10.1038/s41467-021-26485-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Aksu Kuz C., Ning K., Hao S., Cheng F., Qiu J. Role of the membrane-associated accessory protein (MAAP) in adeno-associated virus (AAV) infection. J. Virol. 2024;98 doi: 10.1128/jvi.00633-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Cao M., You H., Hermonat P.L. The X gene of adeno-associated virus 2 (AAV2) is involved in viral DNA replication. PLoS One. 2014;9 doi: 10.1371/journal.pone.0104596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Hermonat P.L., Santin A.D., De Greve J., De Rijcke M., Bishop B.M., Han L., Mane M., Kokorina N. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter. J. Hum. Virol. 1999;2:359–368. [PubMed] [Google Scholar]
- 64.Sun X.L., Peng H.Y. Recent advances in biological control of pest insects by using viruses in China. Virol. Sin. 2007;22:158–162. doi: 10.1007/s12250-007-0017-0. [DOI] [Google Scholar]
- 65.Hussain A.G., Wennmann J.T., Goergen G., Bryon A., Ros V.I.D. Viruses of the fall armyworm spodoptera frugiperda: A review with prospects for biological control. Viruses. 2021;13 doi: 10.3390/v13112220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Lacey L.A., Unruh T.R. Biological control of codling moth (cydia pomonella, lepidoptera: tortricidae) and its role in integrated pest management, with emphasis on entomopathogens. Vedalia. 2005;12:33–60. [Google Scholar]
- 67.van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J. Gen. Virol. 1996;77:2737–2745. doi: 10.1099/0022-1317-77-11-2737. [DOI] [PubMed] [Google Scholar]
- 68.Li Y., Yi X., Zhuang Y., Chu J. Regulation of porcine circovirus type 2-like particles expressed in baculovirus expression system. Bioresour. Bioprocess. 2016;3 doi: 10.1186/s40643-016-0114-8. [DOI] [Google Scholar]
- 69.Zhang H., Qian P., Liu L., Qian S., Chen H., Li X. Virus-Like Particles of Chimeric Recombinant Porcine Circovirus Type 2 as Antigen Vehicle Carrying Foreign Epitopes. Viruses. 2014;6:4839–4855. doi: 10.3390/v6124839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Vail P.V., Sutter G., Jay D.L., Gough D. Reciprocal Infectivity of Nuclear Polyhedrosis Viruses of the Cabbage Looper and Alfalfa Looper. J. Invertebr. Pathol. 1971;17:383–388. doi: 10.1016/0022-2011(71)90013-9. [DOI] [Google Scholar]
- 71.Smith G.E., Summers M.D., Fraser M.J. Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol. Cell Biol. 1983;3:2156–2165. doi: 10.1128/mcb.3.12.2156-2165.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Ayres M.D., Howard S.C., Kuzio J., Lopez-Ferber M., Possee R.D. The complete DNA sequence of Autographa californica Nuclear Polyhedrosis Virus. Virology. 1994;202:586–605. doi: 10.1006/viro.1994.1380. [DOI] [PubMed] [Google Scholar]
- 73.Carstens E.B. AcMNPV as a model for baculovirus DNA replication. Virol. Sin. 2009;24:243–267. doi: 10.1007/s12250-009-3047-y. [DOI] [Google Scholar]
- 74.Summers M.D., Smith G.E. Baculovirus structural polypeptides. Virology. 1978;84:390–402. doi: 10.1016/0042-6822(78)90257-x. [DOI] [PubMed] [Google Scholar]
- 75.Williams G.V., Rohel D.Z., Kuzio J., Faulkner P. A cytopathological investigation of Autographa californica nuclear polyhedrosis virus p10 gene function using insertion/deletion mutants. J. Gen. Virol. 1989;70:187–202. doi: 10.1099/0022-1317-70-1-187. [DOI] [PubMed] [Google Scholar]
- 76.Vlak J.M., Klinkenberg F.A., Zaal K.J., Usmany M., Klinge-Roode E.C., Geervliet J.B., Roosien J., van Lent J.W. Functional studies on the p10 gene of Autographa californica nuclear polyhedrosis virus using a recombinant expressing a p10-β-galactosidase fusion gene. J. Gen. Virol. 1988;69:765–776. doi: 10.1099/0022-1317-69-4-765. [DOI] [PubMed] [Google Scholar]
- 77.Gross C.H., Russell R.L., Rohrmann G.F. Orgyia pseudotsugata baculovirus p10 and polyhedron envelope protein genes: analysis of their relative expression levels and role in polyhedron structure. J. Gen. Virol. 1994;75:1115–1123. doi: 10.1099/0022-1317-75-5-1115. [DOI] [PubMed] [Google Scholar]
- 78.Smith G.E., Fraser M.J., Summers M.D. Molecular engineering of the Autographa californica Nuclear Polyhedrosis Virus genome: Deletion mutations within the polyhedrin gene. J. Virol. 1983;46:584–593. doi: 10.1128/jvi.46.2.584-593.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.van Oers M.M., Pijlman G.P., Vlak J.M. Thirty years of baculovirus-insect cell protein expression: From dark horse to mainstream technology. J. Gen. Virol. 2015;96:6–23. doi: 10.1099/vir.0.067108-0. [DOI] [PubMed] [Google Scholar]
- 80.de Jong L.A., van Oosten L., Pijlman G.P. Scarless Baculovirus Genome Editing Using Lambda-Red Recombineering in E. coli. Methods Mol. Biol. 2024;2829:109–126. doi: 10.1007/978-1-0716-3961-0_8. [DOI] [PubMed] [Google Scholar]
- 81.Wang H., Bian X., Xia L., Ding X., Müller R., Zhang Y., Fu J., Stewart A.F. Improved seamless mutagenesis by recombineering using ccdB for counterselection. Nucleic Acids Res. 2014;42:e37. doi: 10.1093/nar/gkt1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Pijlman G.P., Dortmans J.C.F.M., Vermeesch A.M.G., Yang K., Martens D.E., Goldbach R.W., Vlak J.M. Pivotal Role of the Non- hr Origin of DNA Replication in the Genesis of Defective Interfering Baculoviruses. J. Virol. 2002;76:5605–5611. doi: 10.1128/jvi.76.11.5605-5611.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Pijlman G.P., van Schijndel J.E., Vlak J.M. Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells. J. Gen. Virol. 2003;84:2669–2678. doi: 10.1099/vir.0.19438-0. [DOI] [PubMed] [Google Scholar]
- 84.Luckow V.A., Lee S.C., Barry G.F., Olins P.O. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 1993;67:4566–4579. doi: 10.1128/jvi.67.8.4566-4579.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Hitchman R.B., Possee R.D., King L.A. Baculovirus expression systems for recombinant protein production in insect cells. Recent Pat. Biotechnol. 2009;3:46–54. doi: 10.2174/187220809787172669. [DOI] [PubMed] [Google Scholar]
- 86.Tang Y., Saul J., Nagaratnam N., Martin-Garcia J.M., Fromme P., Qiu J., LaBaer J. Construction of gateway-compatible baculovirus expression vectors for high-throughput protein expression and in vivo microcrystal screening. Sci. Rep. 2020;10 doi: 10.1038/s41598-020-70163-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Zhai Y., Zhang D., Yu L., Sun F., Sun F. SmartBac, a new baculovirus system for large protein complex production. J. Struct. Biol. X. 2019;1 doi: 10.1016/j.yjsbx.2019.100003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Berger I., Fitzgerald D.J., Richmond T.J. Baculovirus expression system for heterologous multiprotein complexes. Nat. Biotechnol. 2004;22:1583–1587. doi: 10.1038/nbt1036. [DOI] [PubMed] [Google Scholar]
- 89.Pijlman G.P., Grose C., Hick T.A.H., Breukink H.E., van den Braak R., Abbo S.R., Geertsema C., van Oers M.M., Martens D.E., Esposito D. Relocation of the attTn7 transgene insertion site in bacmid DNA enhances baculovirus genome stability and recombinant protein expression in insect cells. Viruses. 2020;12:1448. doi: 10.3390/v12121448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Weindler F.W., Heilbronn R. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J. Virol. 1991;65:2476–2483. doi: 10.1128/jvi.65.5.2476-2483.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Wang Z., Deng X., Zou W., Engelhardt J.F., Yan Z., Qiu J. Human Bocavirus 1 Is a Novel Helper for Adeno-associated Virus Replication. J. Virol. 2017;91 doi: 10.1128/jvi.00710-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Ogston P., Raj K., Beard P. Productive Replication of Adeno-Associated Virus Can Occur in Human Papillomavirus Type 16 (HPV-16) Episome-Containing Keratinocytes and Is Augmented by the HPV-16 E2 Protein. J. Virol. 2000;74:3494–3504. doi: 10.1128/jvi.74.8.3494-3504.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Laughlin C.A., Jones N., Carter B.J. Effect of deletions in adenovirus early region 1 genes upon replication of adeno-associated virus. J. Virol. 1982;41:868–876. doi: 10.1128/jvi.41.3.868-876.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Ward P., Dean F.B., O’donnell M.E., Berns K.I. Role of the adenovirus DNA-Binding protein in in vitro adeno-associated virus DNA replication. J. Virol. 1998;72:420–427. doi: 10.1128/jvi.72.1.420-427.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Janik J.E., Huston M.M., Cho K., Rose J.A. Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA. Virology. 1989;168:320–329. doi: 10.1016/0042-6822(89)90272-9. [DOI] [PubMed] [Google Scholar]
- 96.Matsushita T., Elliger S., Elliger C., Podsakoff G., Villarreal L., Kurtzman G.J., Iwaki Y., Colosi P. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 1998;5:938–945. doi: 10.1038/sj.gt.3300680. [DOI] [PubMed] [Google Scholar]
- 97.Doshi J., Couto E., Staiti J., Vandenberghe L.H., Zabaleta N. E2A, VA RNA I, and L4-22k adenoviral helper genes are sufficient for AAV production in HEK293 cells. Mol. Ther. Methods Clin. Dev. 2024;32 doi: 10.1016/j.omtm.2024.101376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Saudan P., Vlach J., Beard P. Inhibition of S-phase progression by adeno associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J. 2000;19:4351–4361. doi: 10.1093/emboj/19.16.4351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Berthet C., Raj K., Saudan P., Beard P. How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc. Natl. Acad. Sci. USA. 2005;102:13634–13639. doi: 10.1073/pnas.0504583102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5. J. Gen. Virol. 1977;36:59–74. doi: 10.1099/0022-1317-36-1-59. [DOI] [PubMed] [Google Scholar]
- 101.Slanina H., Weger S., Stow N.D., Kuhrs A., Heilbronn R. Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication. J. Virol. 2006;80:5241–5250. doi: 10.1128/jvi.02718-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Alazard-Dany N., Nicolas A., Ploquin A., Strasser R., Greco A., Epstein A.L., Fraefel C., Salvetti A. Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events. PLoS Pathog. 2009;5 doi: 10.1371/journal.ppat.1000340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Franzoso F.D., Seyffert M., Vogel R., Yakimovich A., de Andrade Pereira B., Meier A.F., Sutter S.O., Tobler K., Vogt B., Greber U.F., et al. Cell cycle-dependent expression of adeno-associated virus 2 (AAV2) Rep in coinfections with herpes himplex virus 1 (HSV-1) gives rise to a mosaic of cells replicating either AAV2 or HSV-1. J. Virol. 2017;91 doi: 10.1128/jvi.00357-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Ruffing M., Zentgraf H., Kleinschmidt J.A. Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol. 1992;66:6922–6930. doi: 10.1128/jvi.66.12.6922-6930.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Kozak M. The Scanning Model for Translation: An Update. J. Cell Biol. 1989;108:229–241. doi: 10.1083/jcb.108.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Kozak M. Bifunctional Messenger RNAs in Eukaryotes. Cell. 1986;47:481–483. doi: 10.1016/0092-8674(86)90609-4. [DOI] [PubMed] [Google Scholar]
- 107.Kohlbrenner E., Aslanidi G., Nash K., Shklyaev S., Campbell-Thompson M., Byrne B.J., Snyder R.O., Muzyczka N., Warrington K.H., Zolotukhin S. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 2005;12:1217–1225. doi: 10.1016/j.ymthe.2005.08.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Negrete A., Yang L.C., Mendez A.F., Levy J.R., Kotin R.M. Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system. J. Gene Med. 2007;9:938–948. doi: 10.1002/jgm.1092. [DOI] [PubMed] [Google Scholar]
- 109.Wu Y., Jiang L., Geng H., Yang T., Han Z., He X., Lin K., Xu F. A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae. Mol. Ther. Methods Clin. Dev. 2018;10:38–47. doi: 10.1016/j.omtm.2018.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Galibert L., Jacob A., Savy A., Dickx Y., Bonnin D., Lecomte C., Rivollet L., Sanatine P., Boutin Fontaine M., Le Bec C., et al. Monobac system–a single baculovirus for the production of raav. Microorganisms. 2021;9 doi: 10.3390/microorganisms9091799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Aslanidi G., Lamb K., Zolotukhin S. An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells. Proc. Natl. Acad. Sci. USA. 2009;106:5059–5064. doi: 10.1073/pnas.0810614106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Sułek M., Szuster-Ciesielska A. The bioengineering of insect cell lines for biotherapeutics and vaccine production: An updated review. Vaccines (Basel) 2025;13:556. doi: 10.3390/vaccines13060556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Wilde M., Klausberger M., Palmberger D., Ernst W., Grabherr R. Tnao38, high five and Sf9--evaluation of host-virus interactions in three different insect cell lines: baculovirus production and recombinant protein expression. Biotechnol. Lett. 2014;36:743–749. doi: 10.1007/S10529-013-1429-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Kwiatkowska J., Stein E., Romanenko A., Plens-Gałąska M., Podsiadła-Białoskórska M., Szołajska E., Kühn U., Kamieniarz-Gdula K. A beginners guide to Sf9 and Sf21 insect cell line culture and troubleshooting. Sci. Rep. 2025;15 doi: 10.1038/s41598-025-99812-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Meghrous J., Aucoin M.G., Jacob D., Chahal P.S., Arcand N., Kamen A.A. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: From shake flasks to a 20-L bioreactor. Biotechnol. Prog. 2005;21:154–160. doi: 10.1021/bp049802e. [DOI] [PubMed] [Google Scholar]
- 116.Wang F., Sun J., Guo W., Wu Y. Application of the insect cell-baculovirus expression vector system in adeno-associated viral production. Appl. Sci. (Basel). 2024;14:10948. doi: 10.3390/app142310948. [DOI] [Google Scholar]
- 117.Savy A., Kaikkonen M.U., Léger A., Dickx Y., Galibert L., Merten O.W. Genetics instability of wtAAV2 genome and AAV promoter activities in the Baculovirus/Sf9 cells system. PLoS One. 2018;13:e0199866. doi: 10.1371/journal.pone.0199866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Shao-Hua C., Hong-Liang S., Zuo-Hu L. Effect of temperature oscillation on insect cell growth and baculovirus replication. Appl. Environ. Microbiol. 1998;64:2237–2239. doi: 10.1128/aem.64.6.2237-2239.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Aucoin M.G., Perrier M., Kamen A.A. Improving AAV vector yield in insect cells by modulating the temperature after infection. Biotechnol. Bioeng. 2007;97:1501–1509. doi: 10.1002/bit.21364. [DOI] [PubMed] [Google Scholar]
- 120.Wen J., Sargunas J., Carman D., Greenshtein N., Betenbaugh M.J. Tailored cell cycle modulation enhances AAV manufacturing: balancing arrest with adaptive stress responses. bioRxiv. 2026 doi: 10.64898/2026.01.19.700387. Preprint at. [DOI] [Google Scholar]
- 121.Mullick A., Morasse A., Leclerc M., Liu Z., Liu Q.Y., Leclerc S., Momcilovic M., Viau A., Kamen A.A. AAV Assembled Capsids Are Produced in Cells Blocked From Cell Cycle Progression. Biotechnol. Bioeng. 2026;123:273–286. doi: 10.1002/bit.70111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Braunagel S.C., Parr R., Belyavskyi M., Summers M.D. Autographa californica Nucleopolyhedrovirus Infection Results in Sf9 Cell Cycle Arrest at G 2/M Phase. Virology. 1998;244:195–211. doi: 10.1006/viro.1998.9097. [DOI] [PubMed] [Google Scholar]
- 123.Ikeda M., Kobayashi M. Cell-cycle perturbation in Sf9 cells infected with Autographa californica Nucleopolyhedrovirus. Virology. 1999;258:176–188. doi: 10.1006/viro.1999.9706. [DOI] [PubMed] [Google Scholar]
- 124.Van Oers M.M., Vlak J.M. Baculovirus Genomics. Curr. Drug Targets. 2007;8:1051–1068. doi: 10.2174/138945007782151333. [DOI] [PubMed] [Google Scholar]
- 125.Rohrmann G.F. 4th ed. National Center for Biotechnology Information (US); 2019. Baculovirus Molecular Biology. [PubMed] [Google Scholar]
- 126.Nash K., Chen W., Muzyczka N. Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteins. J. Virol. 2008;82:1458–1464. doi: 10.1128/jvi.01968-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Boehm E.M., Gildenberg M.S., Washington M.T. The many roles of PCNA in eukaryotic DNA replication. Enzymes. 2016;39:231–254. doi: 10.1016/bs.enz.2016.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Flint J., Shenk T. Viral trans proteins. Annu. Rev. Genet. 1997;31:177–212. doi: 10.1146/annurev.genet.31.1.177. [DOI] [PubMed] [Google Scholar]
- 129.Malysa A., Zhang X.M., Bepler G. Minichromosome Maintenance Proteins: From DNA Replication to the DNA Damage Response. Cells. 2024;14 doi: 10.3390/cells14010012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Fu Y., Wang R., Liang A. Function analysis of Ac-PCNA and Sf-PCNA during the Autographa californica multiple nucleopolyhedrovirus infection process. Mol. Cell. Biochem. 2018;443:57–68. doi: 10.1007/s11010-017-3210-y. [DOI] [PubMed] [Google Scholar]
- 131.O’Reilly D.R., Crawford A.M., Miller L.K. Viral proliferating cell nuclear antigen. Nature. 1989;337:606. doi: 10.1038/337606a0. [DOI] [PubMed] [Google Scholar]
- 132.Kazlauskas D., Krupovic M., Guglielmini J., Forterre P., Venclovas Č. Diversity and evolution of B-family DNA polymerases. Nucleic Acids Res. 2020;48:10142–10156. doi: 10.1093/nar/gkaa760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Yakobson B., Koch T., Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 1987;61:972–981. doi: 10.1128/JVI.61.4.972-981.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Yakobson B., Hrynko T.A., Peak M.J., Winocour E. Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J. Virol. 1989;63:1023–1030. doi: 10.1128/JVI.63.3.1023-1030.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Maxwell I.H., Terrell K.L., Maxwell F. Autonomous parvovirus vectors. Methods. 2002;28:168–181. doi: 10.1016/S1046-2023(02)00221-9. [DOI] [PubMed] [Google Scholar]
- 136.Monteiro F., Carinhas N., Carrondo M.J.T., Bernal V., Alves P.M. Toward system-level understanding of baculovirus-host cell interactions: From molecular fundamental studies to large-scale proteomics approaches. Front. Microbiol. 2012;3:319. doi: 10.3389/fmicb.2012.00391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Stutika C., Hüser D., Weger S., Rutz N., Heßler M., Heilbronn R. Definition of herpes simplex virus helper functions for the replication of adeno-associated virus type 5. J. Gen. Virol. 2015;96:840–850. doi: 10.1099/vir.0.000034. [DOI] [PubMed] [Google Scholar]
- 138.Milks M.L., Washburn J.O., Willis L.G., Volkman L.E., Theilmann D.A. Deletion of pe38 attenuates AcMNPV genome replication, budded virus production, and virulence in Heliothis virescens. Virology. 2003;310:224–234. doi: 10.1016/S0042-6822(03)00143-0. [DOI] [PubMed] [Google Scholar]
- 139.Sokal N., Nie Y., Willis L.G., Yamagishi J., Blissard G.W., Rheault M.R., Theilmann D.A. Defining the roles of the baculovirus regulatory proteins IE0 and IE1 in genome replication and early gene transactivation. Virology. 2014;468-470:160–171. doi: 10.1016/j.virol.2014.07.044. [DOI] [PubMed] [Google Scholar]
- 140.Berretta M.F., Ferrelli M.L., Salvador R., Sciocco A., Romanowski V. In: Current Issues in Molecular Virology - Viral Genetics and Biotechnological Applications. Romanowski Victor., editor. InTech; 2013. Baculovirus gene expression; pp. 57–78. [DOI] [Google Scholar]
- 141.Mikhailov V.S., Rohrmann G.F. Baculovirus Replication Factor LEF-1 Is a DNA Primase. J. Virol. 2002;76:2287–2297. doi: 10.1128/jvi.76.5.2287-2297.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Yu M., Carstens E.B. Identification of a domain of the baculovirus Autographa californica Multiple Nucleopolyhedrovirus single-strand DNA-binding protein LEF-3 essential for viral DNA replication. J. Virol. 2010;84:6153–6162. doi: 10.1128/jvi.00115-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Iwahori S., Ikeda M., Kobayashi M. Association of Sf9 cell proliferating cell nuclear antigen with the DNA replication site of Autographa californica multicapsid nucleopolyhedrovirus. J. Gen. Virol. 2004;85:2857–2862. doi: 10.1099/vir.0.80114-0. [DOI] [PubMed] [Google Scholar]
- 144.Okano K., Vanarsdall A.L., Rohrmann G.F. Characterization of a Baculovirus Lacking the Alkaline Nuclease Gene. J. Virol. 2004;78:10650–10656. doi: 10.1128/jvi.78.19.10650-10656.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.McLachlin J.R., Miller L.K. Identification and Characterization of vlf-1, a Baculovirus Gene Involved in Very Late Gene Expression. J. Virol. 1994;68:7746–7756. doi: 10.1128/JVI.68.12.7746-7756.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Li Y.I., Wang J., Deng R., Zhang Q., Yang K., Wang X. vlf-1 deletion brought AcMNPV to defect in nucleocapsid formation. Virus Genes. 2005;31:275–284. doi: 10.1007/s11262-005-3242-3. [DOI] [PubMed] [Google Scholar]
- 147.Mikhailov V.S., Rohrmann G.F. Binding of the baculovirus very late expression factor 1 (VLF-1) to different DNA structures. BMC Mol. Biol. 2002;3 doi: 10.1186/1471-2199-3-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Smith M.C., Boutell C., Davido D.J. HSV-1 ICP0: paving the way for viral replication. Future Virol. 2011;6:421–429. doi: 10.2217/fvl.11.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Launer-Felty K., Wong C.J., Cole J.L. Structural analysis of adenovirus VAI RNA defines the mechanism of inhibition of PKR. Biophys. J. 2015;108:748–757. doi: 10.1016/j.bpj.2014.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Mitchell J.K., Byers N.M., Friesen P.D. Baculovirus F-box protein LEF-7 modifies the host DNA damage response to enhance virus multiplication. J. Virol. 2013;87:12592–12599. doi: 10.1128/jvi.02501-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Mitchell J.K., Friesen P.D. Baculoviruses modulate a proapoptotic DNA damage response to promote virus multiplication. J. Virol. 2012;86:13542–13553. doi: 10.1128/jvi.02246-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Li J.J., Cao C., Fixsen S.M., Young J.M., Ono C., Bando H., Elde N.C., Katsuma S., Dever T.E., Sicheri F., et al. Baculovirus protein PK2 subverts eIF2α kinase function by mimicry of its kinase domain C-lobe. Proc. Natl. Acad. Sci. USA. 2015;112:E4364–E4373. doi: 10.1073/pnas.1505481112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Dever T.E., Sripriya R., Mclachlin J.R., Lu J., Fabian J.R., Kimball S.R., Miller L.K. Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2 kinase homolog. Biochemistry. 1998;95:4164–4169. doi: 10.1073/pnas.95.8.4164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Virgolini N., Hagan R., Correia R., Silvano M., Fernandes S., Alves P.M., Clarke C., Roldão A., Isidro I.A. Transcriptome analysis of Sf9 insect cells during production of recombinant Adeno-associated virus. Biotechnol. J. 2023;18:e2200466. doi: 10.1002/biot.202200466. [DOI] [PubMed] [Google Scholar]
- 155.Virgolini N., Silvano M., Hagan R., Correia R., Alves P.M., Clarke C., Roldão A., Isidro I.A. Impact of dual-baculovirus infection on the Sf9 insect cell transcriptome during rAAV production using single-cell RNA-seq. Biotechnol. Bioeng. 2023;120:2588–2600. doi: 10.1002/BIT.28377. [DOI] [PubMed] [Google Scholar]
- 156.Friesen P.D. In: The Baculoviruses. Miller L.K., editor. Springer; 1997. Regulation of baculovirus early gene expression; pp. 141–170. [DOI] [Google Scholar]
- 157.Yu Y., Zhang T., Lu D., Wang J., Xu Z., Zhang Y., Liu Q. Genome-wide nonessential gene identification of Autographa californica multiple nucleopolyhedrovirus. Gene. 2023;863 doi: 10.1016/j.gene.2023.147239. [DOI] [PubMed] [Google Scholar]
- 158.Zhang X., He A., Zong Y., Tian H., Zhang Z., Zhao K., Xu X., Chen H. Improvement of protein production in baculovirus expression vector system by removing a total of 10 kb of nonessential fragments from Autographa californica multiple nucleopolyhedrovirus genome. Front. Microbiol. 2023;14 doi: 10.3389/fmicb.2023.1171500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Passarelli A.L., Miller L.K. Identification and characterization of lef-1, a baculovirus gene involved in late and very late gene expression. J. Virol. 1993;67:3481–3488. doi: 10.1128/jvi.67.6.3481-3488.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Passarelli A.L., Guarino L.A. Baculovirus late and very late gene regulation. Curr. Drug Targets. 2007;8:1103–1115. doi: 10.2174/138945007782151324. [DOI] [PubMed] [Google Scholar]
- 161.Branon T.C., Bosch J.A., Sanchez A.D., Udeshi N.D., Svinkina T., Carr S.A., Feldman J.L., Perrimon N., Ting A.Y. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 2018;36:880–887. doi: 10.1038/nbt.4201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Sears R.M., May D.G., Roux K.J. In: Methods in Molecular Biology. Nuijens T., Schmidt M., editors. Springer; 2019. BioID as a tool for protein-proximity labeling in living cells; pp. 299–313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Roux K.J., Kim D.I., Raida M., Burke B. A promiscuous biotin ligase fusion protein identifies proximal and interacting. J. Cell Biol. 2012;196:801–810. doi: 10.1083/jcb.201112098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Cho K.F., Branon T.C., Udeshi N.D., Myers S.A., Carr S.A., Ting A.Y. Proximity labeling in mammalian cells with TurboID and split-TurboID. Nat. Protoc. 2020;15:3971–3999. doi: 10.1038/s41596-020-0399-0. [DOI] [PubMed] [Google Scholar]
- 165.Galibert L., Merten O.W. Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases. J. Invertebr. Pathol. 2011;107:S80–S93. doi: 10.1016/j.jip.2011.05.008. [DOI] [PubMed] [Google Scholar]
- 166.Krishnan R., Hanania E. Can AAV continue to deliver the promise of gene therapy? Cell Gene Ther. Insights. 2023;09:1089–1096. doi: 10.18609/cgti.2023.143. [DOI] [Google Scholar]
- 167.Merten O.W. Development of Stable Packaging and Producer Cell Lines for the Production of AAV Vectors. Microorganisms. 2024;12:384. doi: 10.3390/microorganisms12020384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Kowshik N.C.S.S., Singh P. Advancing AAV vector manufacturing: challenges, innovations, and future directions for gene therapy. Front. Mol. Med. 2025;5 doi: 10.3389/fmmed.2025.1709095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Joshi P.R.H., Venereo-Sanchez A., Chahal P.S., Kamen A.A. Advancements in molecular design and bioprocessing of recombinant adeno-associated virus gene delivery vectors using the insect-cell baculovirus expression platform. Biotechnol. J. 2021;16:2000021. doi: 10.1002/biot.202000021. [DOI] [PubMed] [Google Scholar]
- 170.Khaparde A., Patra R., Roy S., Babu G R S., Ghosh A. Improving AAV production yield and quality for different serotypes using distinct processing methods. ACS Omega. 2025;10:22657–22670. doi: 10.1021/acsomega.4c10900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Vandenberghe L.H., Xiao R., Lock M., Lin J., Korn M., Wilson J.M. Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing. Hum. Gene Ther. 2010;21:1251–1257. doi: 10.1089/hum.2010.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Shang Y., Wang M., Xiao G., Wang X., Hou D., Pan K., Liu S., Li J., Wang J., Arif B.M., et al. Construction and rescue of a functional synthetic baculovirus. ACS Synth. Biol. 2017;6:1393–1402. doi: 10.1021/acssynbio.7B00028. [DOI] [PubMed] [Google Scholar]
- 173.Guo Y., Hu H., Xiao H., Deng F., Li J., Wang M., Hu Z. Successful rescue of synthetic AcMNPV with a ∼17 kb deletion in the C1 region of the genome. Viruses. 2022;14 doi: 10.3390/v14122780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Guo Y., Hu H., Xiao H., Wang X., Ke X., Li J., Wang M., Hu Z. Genome-wide simplification of the AcMNPV genome using synthetic biology. ACS Synth. Biol. 2025;14:3414–3422. doi: 10.1021/acssynbio.5c00156. [DOI] [PubMed] [Google Scholar]
- 175.Yu Q., Xiong Y., Gao H., Liu J., Chen Z., Wang Q., Wen D. Comparative proteomics analysis of Spodoptera frugiperda cells during Autographa californica multiple nucleopolyhedrovirus infection. Virol. J. 2015;12:115. doi: 10.1186/S12985-015-0346-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
